You've probably heard someone describe an intense cannabis experience as "trippy" or "psychedelic." But does science actually classify cannabis as a psychedelic? Not by the standard definition. The more interesting answer is that researchers now think high-THC cannabis may be able to produce some psychedelic-like effects under certain conditions, and that this has been hard to see in the way cannabis is usually studied.
What Makes Something Psychedelic?
Before looking at cannabis, it helps to know what scientists mean by "psychedelic." Classic psychedelics like LSD, psilocybin and DMT act mainly on one serotonin receptor in the brain, the 5-HT2A receptor. They are known for producing profound changes in perception, thought and sense of self.
Cannabis works through a different system entirely. THC acts on the body's cannabinoid receptors, CB1 and CB2, rather than on the serotonin receptor that defines the classic psychedelics. That difference in mechanism is one reason cannabis is not classed as a psychedelic.
The Scientific Perspective on Cannabis and Perception
The most useful recent work on this question is a literature review by researchers at Johns Hopkins, published online in the Journal of Psychopharmacology in 2023. It looked at whether cannabis can produce the perceptual changes, aversive reactions and mystical-type experiences more typically associated with psychedelics such as psilocybin.
Its conclusion was careful. The authors found that "high-THC cannabis may be able to elicit psychedelic effects, but that these effects may not have been observed in recent controlled research studies due to the doses, set, and settings commonly used." In other words, the conditions in which cannabis is usually studied may not match the conditions in which these effects occur, and that gap could hide effects that happen outside the lab.
The review called for research into high doses of THC in the kind of setting used in psychedelic studies, and the same research group has since registered a clinical study investigating psychedelic effects in psychoactive substances. In August 2026 the group published a pilot from that work: in a psychedelic-therapy setting, a high dose of THC produced a subjective experience similar to psilocybin, and the authors noted that one of the forms of THC they tested could be mistaken for a classic hallucinogen. At a higher dose, the researchers also reported more nausea and longer-lasting effects than they expected. It involved only four participants, so it is a first signal rather than a settled finding, and it was a supervised clinical setting, not everyday use.
The National Institute on Drug Abuse describes the effects more plainly: "Cannabis products with THC can cause changes in mood, thoughts, and perceptions of reality." NIDA also lists altered time perception among cannabis's effects. Those overlap with how people describe psychedelics, even though the mechanism is different.
How Users Experience Cannabis vs Psychedelics
Surveys of people who use both give another angle. A 2020 survey of 319 cannabis and psychedelic consumers, reported by Leafly, found that 75% said their cannabis experiences did not resemble their experiences with psychedelics.
That leaves a minority who do see some resemblance, and the same survey found that some respondents regarded cannabis as having a spiritual or self-expansive side. But for most of the people in that survey, the two were clearly different experiences.
Why Some People Describe Cannabis as Psychedelic
If cannabis is not a psychedelic by mechanism, why does the description keep coming up? The Johns Hopkins review points to dose, and to set and setting, the same factors psychedelic research has long emphasized. Individual variation matters too.
Dose
The review's central point is about dose: the effects in question may depend on amounts of THC higher than those commonly used in controlled studies. That is a statement about why earlier research may have missed something, not a recommendation to seek it out. Unpleasant reactions are part of the picture too: aversive effects were one of the things the review examined.
Set and Setting
"Set" is a person's mindset and expectations; "setting" is the environment. Both terms come from psychedelic research, and the review identifies them as part of why cannabis's effects in a lab may differ from its effects elsewhere.
Individual Differences
People respond to THC differently. The same amount can feel mild to one person and much stronger to another, which is one reason descriptions of cannabis experiences vary so widely.
The Molecular Distinction
From a pharmacological standpoint, cannabis and classic psychedelics remain distinct categories.
Classic psychedelics:
- Act mainly on the serotonin 5-HT2A receptor
- Are known for pronounced visual distortions and changes in sense of self
- Produce tolerance quickly with repeated use
Cannabis:
- Acts mainly on the cannabinoid receptors CB1 and CB2
- Tends to produce subtler perceptual changes at typical doses
- Also produces tolerance with frequent use
The overlap is in some of the reported experience, not in how the substances work.
Edibles and Timing
Edibles deserve a separate mention, because of timing. When cannabis is eaten, it passes through the liver before reaching the rest of the body, and the liver converts part of the THC into a metabolite called 11-hydroxy-THC. Edibles also take much longer to take effect than inhaled cannabis.
California requires a government warning with every edible, and it states that the intoxicating effects of cannabis products may be delayed up to two hours. Taking more before the first amount has taken effect can lead to a stronger experience than intended. We explain how to read the dose and serving size on an edible label in microdosing cannabis: the low-dose approach.
The Bottom Line
Is weed psychedelic? By the standard scientific definition, no. Cannabis acts on a different receptor system from LSD or psilocybin, and in one survey of people who had used both, three in four said the experiences were different.
But the question is not fully closed. A 2023 review found that high-THC cannabis may be able to produce psychedelic-like effects under certain doses, mindsets and settings, and suggested that controlled research had missed them. A small 2026 pilot from the same group has since reported a psilocybin-like experience from a high dose of THC in a clinical setting. That is why the answer is "not by definition, and not usually," rather than a flat no.
If you want to understand what is in a product before you buy it, start with the label. We cover how THC and other cannabinoids differ in cannabinoids 101, and why strain labels say less than you might think in indica vs sativa vs hybrid.
Sources and further reading
- The psychedelic effects of cannabis: A review of the literature — Wolinsky, Barrett and Vandrey, Johns Hopkins, Journal of Psychopharmacology, published online 2023
- Cannabis (Marijuana) — National Institute on Drug Abuse, on how THC affects mood, thought and perception
- Is Weed (Marijuana) a Psychedelic Drug? — Leafly, reporting the 2020 survey of 319 cannabis and psychedelic consumers
- Investigation of Psychedelic Effects in Psychoactive Substances — the Johns Hopkins clinical study registration
- Pilot study comparing the effects of high dose THC to high dose psilocybin and placebo in the set and setting of a classic psychedelic therapy session — Barrett, Wolinsky, Vandrey and colleagues, Psychopharmacology, published online August 2026, a four-participant pilot supported by a gift from the Wana Brand Foundation
- Cal. Code Regs. Tit. 4, Section 17406 — the required government warning, including the two-hour delay statement
This article is for general information for adults 21 and older and is not medical advice. Information is current as of September 30, 2026.
